Company Overview and News

 
PropertyLink gives $693m ESR offer the green light

2018-10-16 theage.com.au
PropertyLink has given its tick of approval to the all-cash $693 million takeover offer from private equity real estate giant, ESR Property.
CNI IOF

 
PropertyLink gives $693m ESR offer the green light

2018-10-16 watoday.com.au
PropertyLink has given its tick of approval to the all-cash $693 million takeover offer from private equity real estate giant, ESR Property.
CNI IOF

 
PropertyLink gives $693m ESR offer the green light

2018-10-16 smh.com.au
PropertyLink has given its tick of approval to the all-cash $693 million takeover offer from private equity real estate giant, ESR Property.
CNI IOF

 
Centuria rejects PropertyLink $755m offer

2018-10-02 theage.com.au
Centuria Industrial REIT has rejected rival PropertyLink's predominately scrip $755 million offer, saying there is uncertainty for its unitholders, given PropertyLink is itself the subject of a non-binding, indicative offer from private equity group, ESR Property.
CNI IOF

 
Centuria rejects PropertyLink $755m offer

2018-10-02 watoday.com.au
Centuria Industrial REIT has rejected rival PropertyLink's predominately scrip $755 million offer, saying there is uncertainty for its unitholders, given PropertyLink is itself the subject of a non-binding, indicative offer from private equity group, ESR Property.
CNI IOF

 
Centuria rejects PropertyLink $755m offer

2018-10-02 smh.com.au
Centuria Industrial REIT has rejected rival PropertyLink's predominately scrip $755 million offer, saying there is uncertainty for its unitholders, given PropertyLink is itself the subject of a non-binding, indicative offer from private equity group, ESR Property.
CNI IOF

 
Canada's Oxford Properties ups ante in fight for IOF

2018-09-13 theage.com.au
Canadian-based Oxford Properties has come back fighting with a higher offer of $5.60 for the listed Investa Office Fund and revealed it has bought out manager Investa Commercial Property Fund's crucial 19.9 per cent stake.
CNI IOF

 
Canada's Oxford Properties ups ante in fight for IOF

2018-09-13 smh.com.au
Canadian-based Oxford Properties has come back fighting with a higher offer of $5.60 for the listed Investa Office Fund and revealed it has bought out manager Investa Commercial Property Fund's crucial 19.9 per cent stake.
CNI IOF

 
Canada's Oxford Property ups ante in fight for IOF

2018-09-13 theage.com.au
Canadian-based Oxford Properties has come back fighting with a higher offer of $5.60 for the listed Investa Office Fund and revealed it has bought out manager Investa Commercial Property Fund's crucial 19.9 per cent stake.
CNI IOF

 
Canada's Oxford Property ups ante in fight for IOF

2018-09-13 smh.com.au
Canadian-based Oxford Properties has come back fighting with a higher offer of $5.60 for the listed Investa Office Fund and revealed it has bought out manager Investa Commercial Property Fund's crucial 19.9 per cent stake.
CNI IOF

 
Centuria metro and industrial funds offer positive growth

2018-08-21 theage.com.au
Property fund Centuria's listed Metropolitan and Industrial REITs are the beneficiaries of strong leasing in the suburban office sector and booming online sales underpinning industrial warehouses.
CMA CNI

 
Centuria metro and industrial funds offer positive growth

2018-08-21 smh.com.au
Property fund Centuria's listed Metropolitan and Industrial REITs are the beneficiaries of strong leasing in the suburban office sector and booming online sales underpinning industrial warehouses.
CMA CNI

 
Centuria Capital, Propertylink look to funds management for growth

2018-08-14 theage.com.au
Centuria Capital will look to boost its $5 billion assets under management through direct acquisitions and by creating new unlisted funds.
CMA CNI

 
Centuria Capital, Propertylink look to funds management for growth

2018-08-14 smh.com.au
Centuria Capital will look to boost its $5 billion assets under management through direct acquisitions and by creating new unlisted funds.
CMA CNI

 
E-commerce drives industrial growth at Propertylink

2018-08-14 theage.com.au
Strong rental growth from an ongoing e-commerce boom in Australia’s eastern states will continue to underpin industrial property specialist Propertylink.
CNI

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:CNI / CENTURIA CAPITAL LIMITED on message board site Silicon Investor.

Canadian National Railway (NYSE:CNI) Canadian National Railway (NYSE:CNI) Canadian National Railway (NYSE:CNI) Get-together!!! Picnic-in-Pittsburgh Get-together!!! Picnic-in-Pittsburgh Get-together!!! Picnic-in-Pittsburgh
Physicianu0027s Computer Net (PCNI) Physicianu0027s Computer Net (PCNI) Physicianu0027s Computer Net (PCNI) The Financial Commerce Network (FCNI) The Financial Commerce Network (FCNI) The Financial Commerce Network (FCNI)
SCNI -- Another internet play? SCNI -- Another internet play? SCNI -- Another internet play? ACNielsen(NYSE:ART) ACNielsen(NYSE:ART) ACNielsen(NYSE:ART)
WGNR... I got a tecnical buy here at $9 WGNR... I got a tecnical buy here at $9 WGNR... I got a tecnical buy here at $9